Amina Ahmed
ORCID: 0000-0001-9494-742X
· 3 papers in corpus
nonrandomized-trial
2026
BACKGROUND: Dual anti-CTLA-4/PD-1 inhibitors show efficacy in numerous malignancies. We are the first to report on the efficacy of ipilimumab-nivolumab immunotherapy in a dedicated cohort of patients with gynecologic clear cell carcinomas (…
2013
other
1991